The owners' initiative will provide clean energy and significantly reduce the stadium’s carbon footprint and electricity ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback